Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 38821-52-2
2. Indoramin Hcl
3. Baratol
4. N-(1-(2-(1h-indol-3-yl)ethyl)piperidin-4-yl)benzamide Hydrochloride
5. Doralese
6. Wy-21,901 Hcl
7. N-[1-[2-(1h-indol-3-yl)ethyl]piperidin-4-yl]benzamide;hydrochloride
8. Dq0z3k8w92
9. N-(1-(2-indol-3-ylethyl)-4-piperidyl)benzamide Monohydrochloride
10. Benzamide, N-(1-(2-(1h-indol-3-yl)ethyl)-4-piperidinyl)-, Monohydrochloride
11. Dsstox_cid_26504
12. Dsstox_rid_81673
13. Dsstox_gsid_46504
14. Indoramin Hydrochloride (usan)
15. Vidora
16. Wydora
17. Baratol (pharmaceutical)
18. Indoramin Hydrochloride [usan]
19. Cas-38821-52-2
20. Ncgc00165810-01
21. Indoramin Hydrochloride [usan:ban]
22. Einecs 254-136-2
23. Indoraminhydrochloride
24. Unii-dq0z3k8w92
25. Indoramine Hydrochloride
26. N-(1-(2-(1h-indol-3-yl)ethyl)-4-piperidinyl)benzamide Hydrochloride
27. Schembl123678
28. Chembl2104941
29. Dtxsid1046504
30. Indoramin Hydrochloride [mi]
31. Tox21_112265
32. Mfcd00242842
33. Akos016011220
34. N-[1-[2-(1h-indol-3-yl)ethyl]-4-piperidinyl] Benzamide Hydrochloride
35. Tox21_112265_1
36. Indoramin Hydrochloride [mart.]
37. Indoramin Hydrochloride [who-dd]
38. Ncgc00165810-02
39. D04532
40. Q27276533
| Molecular Weight | 383.9 g/mol |
|---|---|
| Molecular Formula | C22H26ClN3O |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 5 |
| Exact Mass | 383.1764402 g/mol |
| Monoisotopic Mass | 383.1764402 g/mol |
| Topological Polar Surface Area | 48.1 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 454 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Market Place
ABOUT THIS PAGE
A Indoramin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Indoramin Hydrochloride, including repackagers and relabelers. The FDA regulates Indoramin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Indoramin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Indoramin Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Indoramin Hydrochloride supplier is an individual or a company that provides Indoramin Hydrochloride active pharmaceutical ingredient (API) or Indoramin Hydrochloride finished formulations upon request. The Indoramin Hydrochloride suppliers may include Indoramin Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Indoramin Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Indoramin Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Indoramin Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Indoramin Hydrochloride DMFs exist exist since differing nations have different regulations, such as Indoramin Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Indoramin Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Indoramin Hydrochloride USDMF includes data on Indoramin Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Indoramin Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Indoramin Hydrochloride suppliers with USDMF on PharmaCompass.
Indoramin Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Indoramin Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Indoramin Hydrochloride GMP manufacturer or Indoramin Hydrochloride GMP API supplier for your needs.
A Indoramin Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Indoramin Hydrochloride's compliance with Indoramin Hydrochloride specifications and serves as a tool for batch-level quality control.
Indoramin Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Indoramin Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Indoramin Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Indoramin Hydrochloride EP), Indoramin Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Indoramin Hydrochloride USP).
LOOKING FOR A SUPPLIER?
